Home > News > St. Joseph's Among First in U.S. to Use New Technology
January 19th, 2004
St. Joseph's Among First in U.S. to Use New Technology
Abstract:
Researchers at St. Joseph's Hospital and Medical Center are among the first in the country to use a new molecular diagnostic tool to help develop genetic tests for Alzheimer's disease. St. Joseph's DNA Diagnostic Laboratories validated the test in collaboration with Nanogen, Inc., a company that develops and commercializes molecular diagnostic products for the gene-based testing market.
Source:
CHW
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||